Explore EYLEA HD | EYLEA HD® (aflibercept) Injection HCP
Explore EYLEA HD | EYLEA HD® (aflibercept) Injection HCP
5 months ago
linkedin.com
AAO 2025: Diana Do, MD, reviews the real-world use of aflibercept 8 mg | Ophthalmology Times - Clinical Insights for Eye Specialists
AAO 2025: Diana Do, MD, reviews the real-world use of aflibercept 8 mg | Ophthalmology Times - Clinical Insights for Eye Specialists
6 months ago
ophthalmologytimes.com
La FDA américaine approuve EYDENZELT®? (aflibercept-boav), le biosimilaire de Celltrion référencé à EYLEA®? (aflibercept)
La FDA américaine approuve EYDENZELT®? (aflibercept-boav), le biosimilaire de Celltrion référencé à EYLEA®? (aflibercept)
7 months ago
zonebourse.com
Celltrion obtient l'approbation de Santé Canada pour Eydenzelt®, un biosimilaire d'Eylea® (aflibercept 2 mg)
Celltrion obtient l'approbation de Santé Canada pour Eydenzelt®, un biosimilaire d'Eylea® (aflibercept 2 mg)
5 months ago
zonebourse.com
Regeneron Pharmaceuticals : FDA Advisory Committee Provides Guidance on EYLEA® (aflibercept) Injection as a New Treatment for Preterm Infants with Retinopathy of Prematurity (ROP)
Regeneron Pharmaceuticals : FDA Advisory Committee Provides Guidance on EYLEA® (aflibercept) Injection as a New Treatment for Preterm Infants with Retinopathy of Prematurity (ROP)
Jan 9, 2023
marketscreener.com
Phase 3 Clinical Trial Data for EYLEA HD® (aflibercept) Injection 8 mg for the Treatment of Wet AMD - Eyetube
Phase 3 Clinical Trial Data for EYLEA HD® (aflibercept) Injection 8 mg for the Treatment of Wet AMD - Eyetube
Mar 13, 2025
eyetube.net
Phase 2/3 Clinical Trial Data for EYLEA HD® (aflibercept) Injection 8 mg for the Treatment of DME - Eyetube
Phase 2/3 Clinical Trial Data for EYLEA HD® (aflibercept) Injection 8 mg for the Treatment of DME - Eyetube
Apr 4, 2025
eyetube.net
Regeneron Pharmaceuticals, Inc.: EYLEA HD (aflibercept) Injection 8 mg sBLA Accepted for FDA Priority Review for Both the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing in Approved ...
Apr 17, 2025
finanznachrichten.de
Regeneron Pharmaceuticals, Inc.: Regeneron Provides Update on EYLEA HD (aflibercept) Injection 8 mg Supplemental Biologics License Application
Apr 21, 2025
finanznachrichten.de
Regeneron Pharmaceuticals, Inc.: EYLEA HD (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications
5 months ago
finanznachrichten.de
Regeneron Pharmaceuticals, Inc.: EYLEA HD (aflibercept) Injection 8 mg Positive Phase 3 Results in Patients with Macular Edema following Retinal Vein Occlusion Presented at Angiogenesis Meeting
Feb 10, 2025
finanznachrichten.de
Regeneron Pharmaceuticals, Inc.: Three-Year Results for EYLEA HD (aflibercept) Injection 8 mg in Patients with Wet Age-related Macular Degeneration Demonstrate Continued Durable Vision Gains and Anatomic Improvements with ...
9 months ago
finanznachrichten.de
Flexible Dosing for High-Dose Aflibercept: The Data - Eyetube
6 months ago
eyetube.net
High-Dose Aflibercept: 48-Week Data - Eyetube
Aug 8, 2023
eyetube.net
Dosing Considerations with 8 mg Aflibercept - Eyetube
5 months ago
eyetube.net
Extension Data for High-Dose Aflibercept - Eyetube
Oct 28, 2024
eyetube.net
European Medicines Agency Recommends Market Approval of AVT06, Alvotech's Proposed Biosimilar to Eylea (aflibercept)
10 months ago
finanznachrichten.de
A Closer Look at 8 mg Aflibercept - Eyetube
Aug 8, 2023
eyetube.net
US FDA Approves Celltrion's EYLEA Biosimilar for Multiple Retinal Diseases
7 months ago
marketscreener.com
VIDEO: Specialist shares positive experience with Eylea HD
Nov 6, 2024
healio.com
Brolucizumab and Aflibercept in HAWK and HARRIER - Eyetube
May 13, 2020
eyetube.net
Real-World Data for 8 mg Aflibercept - Eyetube
1 year ago
eyetube.net
Aflibercept 8 mg, faricimab show real-world treatment interval extension, safety
6 months ago
healio.com
Switching from Bevacizumab to Aflibercept 8 mg in a Neovascular AMD Patient After Handoff from a Colleague - Eyetube
7 months ago
eyetube.net
VIDEO: Aflibercept 8 mg provides extended dosing intervals, visual benefits in DME
Nov 14, 2024
healio.com
VIDEO: Real-world data show extended injection intervals with aflibercept 8 mg
6 months ago
healio.com
Switching from Aflibercept to Faricimab in Wet AMD Patients - Eyetube
Dec 19, 2024
eyetube.net
Aflibercept 8 mg in nAMD: Outcomes After Switching From Faricimab - Eyetube
7 months ago
eyetube.net
2:16
For diabetic macular edema, the relative efficacy of treatment with aflibercept monotherapy as compared with bevacizumab first, with a switch to aflibercept if response is insufficient, is unclear. New research findings are summarized in a short video. https://nej.md/3QbqFb0 | The New England Journal of Medicine
2.5K viewsAug 24, 2022
FacebookThe New England Journal of Medicine
Regeneron's EYLEA SBLA For 16-week Dosing Regimen In Diabetic Retinopathy Accepted For FDA Review
Jun 29, 2022
nasdaq.com
See more